Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Donnell

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Head Trauma Rehabilitation|March 12, 2013
Screening for postdeployment conditions: development and cross-validation of an embedded validity scale in the neurobehavioral symptom inventoryRodney D Vanderploeg, Douglas B Cooper, Heather G Belanger, et al.
Journal of Chemical Ecology|December 7, 2013
Isoflavonoid feeding deterrents forCostelytra zealandica Structure - Activity relationshipsG A Lane, D R Biggs, G B Russell, et al.
The Open AIDS Journal|October 11, 2012
Use of HIV case surveillance system to design and evaluate site-randomized interventions in an HIV prevention study: HPTN 065Deborah J Donnell, H Irene Hall, Theresa Gamble, et al.
Clinical Trials (London, England)|September 2, 2022
Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trialBrett S Hanscom, Deborah J Donnell, Thomas R Fleming, et al.
American Journal of Medical Genetics|March 1, 1987
Facial effects of fetal alcohol exposure: assessment by photographs and morphometric analysisS K Clarren, P D Sampson, J Larsen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2016
Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current EvidenceBrett Hanscom, Holly E Janes, Peter D Guarino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 23, 2019
Predicted Effectiveness of Daily and Nondaily Preexposure Prophylaxis for Men Who Have Sex With Men Based on Sex and Pill-taking Patterns From the Human Immuno Virus Prevention Trials Network 067/ADAPT StudyDobromir Dimitrov, James R Moore, Daniel Wood, et al.
Plos One|February 24, 2023
Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 studyGeetha Beauchamp, Sybil Hosek, Deborah J Donnell, et al.
Lancet Regional Health. Americas|February 27, 2023
Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083Kate M Mitchell, Marie-Claude Boily, Brett Hanscom, et al.
Nature Medicine|October 5, 2023
Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherenceMia Moore, Sarah Stansfield, Deborah J Donnell, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Head Trauma Rehabilitation|March 12, 2013
Screening for postdeployment conditions: development and cross-validation of an embedded validity scale in the neurobehavioral symptom inventoryRodney D Vanderploeg, Douglas B Cooper, Heather G Belanger, et al.
Journal of Chemical Ecology|December 7, 2013
Isoflavonoid feeding deterrents forCostelytra zealandica Structure - Activity relationshipsG A Lane, D R Biggs, G B Russell, et al.
The Open AIDS Journal|October 11, 2012
Use of HIV case surveillance system to design and evaluate site-randomized interventions in an HIV prevention study: HPTN 065Deborah J Donnell, H Irene Hall, Theresa Gamble, et al.
Clinical Trials (London, England)|September 2, 2022
Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trialBrett S Hanscom, Deborah J Donnell, Thomas R Fleming, et al.
American Journal of Medical Genetics|March 1, 1987
Facial effects of fetal alcohol exposure: assessment by photographs and morphometric analysisS K Clarren, P D Sampson, J Larsen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2016
Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current EvidenceBrett Hanscom, Holly E Janes, Peter D Guarino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 23, 2019
Predicted Effectiveness of Daily and Nondaily Preexposure Prophylaxis for Men Who Have Sex With Men Based on Sex and Pill-taking Patterns From the Human Immuno Virus Prevention Trials Network 067/ADAPT StudyDobromir Dimitrov, James R Moore, Daniel Wood, et al.
Plos One|February 24, 2023
Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 studyGeetha Beauchamp, Sybil Hosek, Deborah J Donnell, et al.
Lancet Regional Health. Americas|February 27, 2023
Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083Kate M Mitchell, Marie-Claude Boily, Brett Hanscom, et al.
Nature Medicine|October 5, 2023
Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherenceMia Moore, Sarah Stansfield, Deborah J Donnell, et al.
Pageof 6